SNPS

Synopsys
D

SNPS

Arincen72/100B

Synopsys operating income 1990–2026

Synopsys's operating income in Q3 FY2026, the three months to 31 July 2026, was 357.49M USD, up 116.3% on the same quarter a year before. Synopsys's operating income over the last twelve months was 918.25M USD, down 16.9% on the twelve months before. In fiscal year 2025 it was 914.93M USD, down 32.5% on the year before.

Last updated 6 Nov 2026 · Next report 8 Dec 2026

Operating income

Operating income · +13.1% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM31 Jul 2026918.25M-16.85%9.75%6.82B72.38%3.73B
FY202531 Oct 2025914.93M-32.51%12.97%5.43B76.98%2.50B
FY202431 Oct 20241.36B+6.48%22.13%4.88B79.68%1.85B
FY202331 Oct 20231.27B+10.84%23.94%4.29B80.62%1.56B
FY202231 Oct 20221.15B+56.33%24.89%3.72B80.54%1.33B
FY202131 Oct 2021734.79M+18.49%17.48%3.34B79.50%1.01B
FY202031 Oct 2020620.14M+19.20%16.83%2.89B78.44%853.29M
FY201931 Oct 2019520.23M+44.42%15.48%2.61B77.60%758.84M
FY201831 Oct 2018360.23M+3.64%11.54%2.39B76.42%588.36M
FY201731 Oct 2017347.56M+9.50%12.76%2.07B75.99%579.84M
FY201631 Oct 2016317.40M+19.11%13.10%1.88B77.59%540.35M
FY201531 Oct 2015266.47M+7.14%11.88%1.72B76.86%496.25M
FY201431 Oct 2014248.72M+0.90%12.09%1.60B77.79%466.86M
FY201331 Oct 2013246.49M+29.72%12.56%1.51B76.89%464.77M
FY201231 Oct 2012190.02M-10.72%10.82%1.36B77.64%359.97M
FY201131 Oct 2011212.84M+15.61%13.86%1.20B77.83%347.76M
FY201031 Oct 2010184.11M-11.59%13.33%1.10B79.64%285.31M
FY200931 Oct 2009208.25M-4.96%15.31%1.09B79.88%311.90M
FY200831 Oct 2008219.11M+85.62%16.39%1.08B80.64%316.26M
FY200731 Oct 2007118.04M+301.07%9.74%978.20M80.68%226.61M
FY200631 Oct 200629.43M—2.69%872.03M79.60%144.72M
FY200531 Oct 2005-59.85M-167.00%-6.03%737.30M74.33%114.74M
FY200431 Oct 200489.32M-54.17%8.18%937.62M85.85%386.30M
FY200331 Oct 2003194.91M—16.56%1.03B87.47%491.72M
FY200231 Oct 2002-80.32M—-8.86%733.38M80.90%123.48M
FY200131 Oct 2001-251.00K-100.23%-0.04%550.23M80.87%64.91M
FY200031 Oct 2000106.89M-54.63%13.64%707.95M90.32%170.66M
FY199930 Sept 1999235.60M+33.03%29.23%743.40M92.22%287.60M
FY199830 Sept 1998177.10M+41.00%24.67%668.30M93.09%221.30M
FY199730 Sept 1997125.60M+34.76%19.41%599.90M92.72%165.40M
FY199630 Sept 199693.20M+79.23%17.73%489.00M93.04%122.10M
FY199530 Sept 199552.00M+69.93%19.59%250.40M94.31%67.50M
FY199430 Sept 199430.60M+53.00%15.61%181.60M92.65%42.70M
FY199330 Sept 199320.00M+90.48%18.52%99.50M92.13%27.70M
FY199230 Sept 199210.50M+105.88%16.67%57.00M90.48%15.70M
FY199130 Sept 19915.10M0.00%12.59%36.80M90.86%8.80M
FY199030 Sept 19905.10M—23.08%20.30M91.86%6.30M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Synopsys's operating income

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.